dazodalibep   Click here for help

GtoPdb Ligand ID: 13453

Synonyms: MEDI-4920 | MEDI4920 | VIB 4920 | VIB-4920 | VIB4920
Immunopharmacology Ligand
Compound class: Peptide
Comment: Dazodalibep (VIB4920, formerly MEDI4920) is a fusion protein that is designed to bind to and neutralise the biological actions of the CD40 ligand (CD40L) [1-2]. Structurally dazodalibep contains two tandem human Tn3 tenascin C modules (that bind CD40L [3]) linked to human serum albumin. Previous studies have demonstrated that anti-CD40L antibodies can cause thromboembolic adverse events that arise through antibody Fc-mediated cross-linking between FcγRIIa and CD40L on platelets. The dazodalibep Fc negative fusion protein approach was initiated to mitigate these platelet-related safety issues.
Classification Click here for help
Compound class Peptide
International Nonproprietary Names Click here for help
INN number INN
11399 dazodalibep
Synonyms Click here for help
MEDI-4920 | MEDI4920 | VIB 4920 | VIB-4920 | VIB4920
Database Links Click here for help
GtoPdb PubChem SID 500839863
Search PubMed clinical trials dazodalibep
Search PubMed titles dazodalibep
Search PubMed titles/abstracts dazodalibep